Determination of the blood glucose lowering property of the crude methanolic extract of the ripe fruit pulp of Calamus manillensis (Arecacease) on Alloxan-induced Diabetic Sprague Dawley Rats /
Batugal, Ivy L.
Determination of the blood glucose lowering property of the crude methanolic extract of the ripe fruit pulp of Calamus manillensis (Arecacease) on Alloxan-induced Diabetic Sprague Dawley Rats / Ivy L. Batugal [and four others] - Manila : National University, 2015 - x, 90 leaves : illustrations ; 29 cm.
Includes bibliographical references.
Title page -- Approval Sheet -- Acknowledgement -- Abstract -- Table of contents -- List of Tables -- List of Figures -- List of Appendices -- 1. The Problem and its Background -- 2. Review of Related Literature -- 3. Research Methods -- 4. Presentation, Analysis and Interpretation of Data -- 5. Summary, Conclusion and Recommendation -- References -- Appendices -- Curriculum Vitae.
The percolated crude methanolic extract of the fruit pulp of Calamus manillensis (Arecaccae) was tested to determine its potential blood glucose lowering property against the standard drug Glibenclamide.
UGT CAH BSPHAR .B38 2015
Determination of the blood glucose lowering property of the crude methanolic extract of the ripe fruit pulp of Calamus manillensis (Arecacease) on Alloxan-induced Diabetic Sprague Dawley Rats / Ivy L. Batugal [and four others] - Manila : National University, 2015 - x, 90 leaves : illustrations ; 29 cm.
Includes bibliographical references.
Title page -- Approval Sheet -- Acknowledgement -- Abstract -- Table of contents -- List of Tables -- List of Figures -- List of Appendices -- 1. The Problem and its Background -- 2. Review of Related Literature -- 3. Research Methods -- 4. Presentation, Analysis and Interpretation of Data -- 5. Summary, Conclusion and Recommendation -- References -- Appendices -- Curriculum Vitae.
The percolated crude methanolic extract of the fruit pulp of Calamus manillensis (Arecaccae) was tested to determine its potential blood glucose lowering property against the standard drug Glibenclamide.
UGT CAH BSPHAR .B38 2015